{"nct_id":"NCT02732119","title":"Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2016-06-14","start_date_type":"ACTUAL","primary_completion_date":"2020-02-25","primary_completion_date_type":"ACTUAL","completion_date":"2020-02-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}